Analysts think ARMP stock price could increase by 357%
Jun 08, 2025, 11:26 AM
5.97%
What does ARMP do
Armata Pharmaceuticals is a clinical-stage biotechnology company based in Los Angeles, focusing on bacteriophage therapeutics for drug-resistant infections, employing 66 staff. Its lead candidates target Pseudomonas aeruginosa and Staphylococcus aureus infections.
3 analysts think ARMP stock price will increase by 356.72%. The current median analyst target is $9.18 compared to a current stock price of $2.01. The lowest analysts target is $9.09 and the highest analyst target is $9.45.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
